DENVER–(BUSINESS WIRE)–HeartHero announces the closing of its oversubscribed Series A funding round. This funding secures a pathway for Elliot, an industry disruptive Automated External Defibrillator (AED), to be submitted for FDA Class III approval and CE mark. This round provides resources for high-volume manufacturing and launches HeartHero’s unique go-to-market strategy for […]
Financial
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
Westport, CT, July 24, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Ms. Julie Stephenson, BSN, MBA joined the Company as Senior Director of Clinical Affairs. […]
Boston Scientific Announces Results For Second Quarter 2019
MARLBOROUGH, Mass., July 24, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.631 billion during the second quarter of 2019. This represents growth of 5.6 percent on a reported basis, 8.0 percent on an operational1 basis and 6.3 percent on an organic2 basis, all compared to the prior year period. The company reported […]
Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company
MENLO PARK, Calif., July 23, 2019 /PRNewswire/ — Ablacon Inc. announced today that it has entered into a $10 millionventure debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2 million equity investment in the Company. This financing will help fund Ablacon’s first multicenter randomized clinical trial for Ablamap, an advanced mapping […]
Edwards Lifesciences Reports Second Quarter Results
IRVINE, Calif., July 23, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2019. Second Quarter and Recent Highlights Sales grew 15% to $1.1 billion; underlying1 sales grew 14% TAVR sales grew 16%; underlying […]
Medtronic Canada Recognized as One of the Best Workplaces™ in Healthcare in 2019
BRAMPTON, Ontario, July 23, 2019 (GLOBE NEWSWIRE) — Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT) — one of the world’s largest medical technology, services, and solutions company — announced today that it has been certified as a Great Place to WorkTM and has also made the list of 2019 Best […]
Philips’ Second Quarter Results 2019
Philips delivers Q2 sales of EUR 4.7 billion, with 6% comparable sales growth and 8% comparable order intake growth; income from continuing operations increases to EUR 260 million and Adjusted EBITA margin improves to 11.8% Second-quarter highlights Sales in the quarter amounted to EUR 4.7 billion, with 6% comparable sales […]
Amarin Announces $400,000,000 Public Offering of American Depositary Shares
BEDMINSTER, N.J. and DUBLIN, Ireland, July 17, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering of $400,000,000 of its American Depositary Shares pursuant to a shelf registration. All of the shares in the proposed offering are to be sold […]
Olivier Chaudoir Joins BioSig as Director of Marketing
Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Mr. Olivier Chaudoir joined the Company as Director of Marketing. Mr. Chaudoir brings to […]
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency
VANCOUVER, July 17, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has received written notification (the “Nasdaq […]



